HU9401686D0 - Piperazine derivatives as 5-ht1a antagonists - Google Patents

Piperazine derivatives as 5-ht1a antagonists

Info

Publication number
HU9401686D0
HU9401686D0 HU9401686A HU9401686A HU9401686D0 HU 9401686 D0 HU9401686 D0 HU 9401686D0 HU 9401686 A HU9401686 A HU 9401686A HU 9401686 A HU9401686 A HU 9401686A HU 9401686 D0 HU9401686 D0 HU 9401686D0
Authority
HU
Hungary
Prior art keywords
alkyl
aryl
hydrogen
cycloalkyl
carbon atoms
Prior art date
Application number
HU9401686A
Other languages
English (en)
Other versions
HUT70755A (en
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of HU9401686D0 publication Critical patent/HU9401686D0/hu
Publication of HUT70755A publication Critical patent/HUT70755A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
HU9401686A 1991-12-05 1992-12-01 Piperazine derivatives as 5-ht1a antagonists, pharmaceutical compositions containing them and process for their preparation HUT70755A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125900A GB9125900D0 (en) 1991-12-05 1991-12-05 Piperazine derivatives

Publications (2)

Publication Number Publication Date
HU9401686D0 true HU9401686D0 (en) 1994-09-28
HUT70755A HUT70755A (en) 1995-10-30

Family

ID=10705770

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9401686A HUT70755A (en) 1991-12-05 1992-12-01 Piperazine derivatives as 5-ht1a antagonists, pharmaceutical compositions containing them and process for their preparation
HU95P/P00337P HU211518A9 (en) 1991-12-05 1995-06-22 Piperazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00337P HU211518A9 (en) 1991-12-05 1995-06-22 Piperazine derivatives

Country Status (22)

Country Link
US (1) US5710149A (hu)
EP (1) EP0625977B1 (hu)
JP (1) JP3262333B2 (hu)
KR (1) KR100244626B1 (hu)
AT (1) ATE162527T1 (hu)
AU (1) AU658242B2 (hu)
BR (1) BR9206861A (hu)
CA (1) CA2124680C (hu)
DE (1) DE69224212T2 (hu)
DK (1) DK0625977T3 (hu)
ES (1) ES2111654T3 (hu)
FI (1) FI942635A0 (hu)
GB (2) GB9125900D0 (hu)
GR (1) GR3025988T3 (hu)
HU (2) HUT70755A (hu)
IL (1) IL103944A (hu)
MX (1) MX9206939A (hu)
NZ (1) NZ246007A (hu)
RU (1) RU2125566C1 (hu)
TW (1) TW306921B (hu)
WO (1) WO1993011122A1 (hu)
ZA (1) ZA929317B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9419024D0 (en) * 1994-09-21 1994-11-09 Wyeth John & Brother Ltd Bicyclic carboxamides
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US5466688A (en) * 1994-10-20 1995-11-14 American Home Products Corporation Pyrido[3,4-B]indole derivatives as serotonergic agents
US5439915A (en) * 1994-10-20 1995-08-08 American Home Products Corporation Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents
US5451584A (en) * 1994-11-10 1995-09-19 American Home Products Corporation N-alkynyl carboxamides as sertonergic agents
US5541179A (en) * 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
US6482827B1 (en) * 1997-07-10 2002-11-19 Pharmacia & Upjohn S.P.A. Matrix metalloproteinase inhibitors
EP1087954A1 (en) * 1998-06-15 2001-04-04 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
TW200700413A (en) * 2005-03-01 2007-01-01 Wyeth Corp Crystalline and amorphous 4-cyano-n-{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
AU2008251259B2 (en) * 2007-05-14 2013-02-14 Sk Biopharmaceuticals Co., Ltd. Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
US8322764B2 (en) 2010-06-11 2012-12-04 Mag-Lok Tools, Inc. Modular long handled tool component system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
DK0395313T3 (da) * 1989-04-22 2000-06-19 American Home Prod Tertiære alkyl-funktionaliserede piperazin-derivater
EP0395312B1 (en) * 1989-04-22 1999-05-12 JOHN WYETH & BROTHER LIMITED Piperazine derivatives
US4935511A (en) * 1989-09-26 1990-06-19 Rorer Pharmaceutical Corporation Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists
GB9022790D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB9112697D0 (en) * 1991-06-13 1991-07-31 Shell Int Research Biocidal compounds
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9308725D0 (en) * 1993-04-27 1993-06-09 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
US5710149A (en) 1998-01-20
JPH07501803A (ja) 1995-02-23
EP0625977A1 (en) 1994-11-30
WO1993011122A1 (en) 1993-06-10
FI942635A (fi) 1994-06-03
FI942635A0 (fi) 1994-06-03
GB9125900D0 (en) 1992-02-05
GB2262093A (en) 1993-06-09
IL103944A0 (en) 1993-05-13
MX9206939A (es) 1993-06-01
RU94030476A (ru) 1996-04-20
IL103944A (en) 1997-06-10
RU2125566C1 (ru) 1999-01-27
GB2262093B (en) 1995-06-07
KR100244626B1 (ko) 2000-05-01
ES2111654T3 (es) 1998-03-16
GR3025988T3 (en) 1998-04-30
CA2124680C (en) 2004-02-17
ZA929317B (en) 1994-06-01
BR9206861A (pt) 1995-11-21
AU2953792A (en) 1993-06-28
DE69224212D1 (de) 1998-02-26
DE69224212T2 (de) 1998-04-30
AU658242B2 (en) 1995-04-06
EP0625977B1 (en) 1998-01-21
TW306921B (hu) 1997-06-01
JP3262333B2 (ja) 2002-03-04
ATE162527T1 (de) 1998-02-15
DK0625977T3 (da) 1998-05-04
HU211518A9 (en) 1995-11-28
NZ246007A (en) 1995-04-27
HUT70755A (en) 1995-10-30
CA2124680A1 (en) 1993-06-10
GB9225121D0 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
GR3025988T3 (en) Piperazine derivatives as 5-ht1a antagonists.
GB2248616B (en) Piperazine derivatives
KR100190256B1 (en) Antiarrhythmic methanesulfonamides
GB2254324B (en) Piperazine derivatives
GR3007087T3 (hu)
EP0089730A3 (en) Guanidino heterocyclicphenylamidines, processes for their preparation and their pharmaceutical use
ATE124948T1 (de) Pharmazeutisch wirksame pteridinderivate.
IT1210914B (it) Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.